Respiratory Flashcards
percentage oxygen delivered by nasal cannula at 1,2 and 4 litres
1 litre- 24%
2 litre- 28%
4 litre - 36%
Rough equivalents nasal canulla to venturi masks
1 litre nasal canula= 24%, blue venturi= 24%
2 litre nasal canula= 28%, white venturi= 28%
4 litre nasal; canula= 36%, yellow venturi= 35%
Blue Venturi mask oxygen flow rate and % oxygen delivered
flow rate= 2-4L
% oxygen delivered= 24%
white Venturi mask oxygen flow rate and % oxygen delivered
flow rate= 4-6L
% oxygen delivered= 28%
Yellow Venturi mask oxygen flow rate and % oxygen delivered
flow rate= 8-12 L
% oxygen delivered= 35%
Red Venturi mask oxygen flow rate and % oxygen delivered
flow rate= 10-15 L
% oxygen delivered= 40%
Green Venturi mask oxygen flow rate and % oxygen delivered
flow rate= 12-15 L
% oxygen delivered= 60%
simple face mask oxygen flow rate and % oxygen delivered
flow rate= 5-10 L
% oxygen delivered= 30-40%
Non-rebreather mask (reservoir mask) oxygen flow rate and % oxygen delivered
flow rate= 15 L
% oxygen delivered= 70%
Medications contra-inidicated in asthmatics
- Beta-blockers (contra-indicated)
- NSAIDs (C/I if previous exacerbation related to NSAID or aspirin use)
- adenosine
6 Indications of hxt of severe asthma
Admission should be considered for patients with a history of severe asthma and any adverse psychosocial factor regardless of the severity of the current episode.
- Previous near-fatal asthma (ventilation, ICU)
- Previous admission for asthma in the last year
- Requiring maintenance therapy of 3 or more classes of asthma medication
- Heavy use of β2 agonist
- Repeated ED attendances with asthma
- ‘Brittle asthma’ (uncontrolled asthma despite maximum maintenance treatment or recurrent sudden severe episodes when asthma well controlled)
Moderate asthma features
Moderate acute asthma:
- PEFR 51-75% best or predicted
- No features of acute severe asthma
Mild asthma exacerbation:
- PEFR >75% best or predicted
- No features of acute severe asthma
Acute Severe asthma features (4)
The absence of any life-threatening feature and presence of any one of the following factors indicates that the current exacerbation is severe.
- PEFR <50% best or predicted
- Respiratory rate 25/min
- Heart rate 110/min
- Inability to complete sentences in one breath
Life threatening asthma features (9)
The presence of any one of the following signs or results indicates that the current exacerbation is life-threatening.
- Reduced conscious level
- Signs of exhaustion
- Hypotension
- Arrhythmia
- Cyanosis
- Poor air entry/ poor respiratory effort
- Silent chest
- PEFR <33% best or predicted
- SpO2 <92% or PaCO2 normal (4.6-6.0 kPa)
Near Fatal asthma features
Raised PaCO2 and/or needing high inflation pressures if ventilated.
Indications for ITU involvement asthmatics
- Deteriorating PEFR
- Persistent or worsening hypoxia
- Hypercapnea (or falling pH on arterial gas sample)
- Exhaustion, feeble respiration
- Reduced conscious level
- Respiratory arrest
what complication to consider if sudden deterioration of asthma patient
spontaneous pneumothorax
Always consider a spontaneous pneumothorax as a cause of sudden deterioration in asthmatics.
Chest percussion and tracheal position should be assessed since asthmatics are at risk of developing secondary spontaneous pneumothoraces. Failure to recognise a pneumothorax or tension pneumothorax as the cause of sudden deterioration in asthmatics is associated with a significant mortality. This will be exacerbated if the patient is intubated and ventilated.
Indication for mag sulfate in asthma
- severe asthma not responding to broncholdilater
-life threatening asthma
BTS says can give 50% magnesium sulfate at 1.2-2g (4-8mmol) over 20 minutes
fractional exhaled nitric oxide suggestive of asthma
> 40ppb
Spirometry in asthma
FEV1: FVC <70
Reversibility testing: an FEV1 increase >12% or 200mls, improvement of >400mls is strongly suggestive (after bronchodilator or trial of oral/inhaled steroids)
Role of PEFR monitoring in diagnosing asthma (atleast BD for 2-4 weeks)
If there is diagnostic uncertainty based on FeNO and Spirometry
> 20% variability would be expected
NICE 7 Steps chronic asthma management
Step 1: SABA alone (minority of patients)
Step 2: low dose ICS
Step 3: add LTRA
Step 4: add LABA and review LTRA
Step 5: MART Regime
Step 6: Moderate dose ICS
Step 7: High Dose ICS. LAMA or theophylline, and refer to asthma specialist
PEFR criteria before discharging and asthmatic patient
- PEFR >75% patient’s best/predicted value
- duirnal variability on PEFR monitoring should be <25%
stepwise